Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring
Top Cited Papers
- 29 January 2004
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (5) , 482-492
Abstract
Although some reports suggest that testosterone-replacement therapy may provide benefits for aging men, considerable controversy remains regarding indications for its use. Neither large-scale nor long-term studies have been initiated, in part because of theoretical concern regarding the risks associated with testosterone therapy, especially the possible stimulation of prostate cancer. This article discusses what is known (and not known) about the risks of testosterone-replacement therapy and provides recommendations for monitoring men who are receiving testosterone.Keywords
This publication has 67 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Androgen administration in middle‐aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volumeInternational Journal of Andrology, 2002
- The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young MenThe Journal of Clinical Endocrinology & Metabolism, 2002
- Androgen Replacement Therapy in the Aging Male--A Critical EvaluationThe Journal of Clinical Endocrinology & Metabolism, 2001
- TestosteroneDrugs & Aging, 2000
- Emerging Issues in Androgen Replacement TherapyThe Journal of Clinical Endocrinology & Metabolism, 1997
- The age‐related decline of androgen levels in men: clinically significant?British Journal of Urology, 1996
- Changes in Lipoprotein-Lipid Levels in Normal Men Following Administration of Increasing Doses of Testosterone CypionateClinical Journal of Sport Medicine, 1996
- Longitudinal evaluation of serum androgen levels in men with and without prostate cancerThe Prostate, 1995
- Multiple hepatic adenomas after long-term therapy with testosterone enanthateJournal of Hepatology, 1985